Metamizol Noridem

Metamizole, the active ingredient in Metamizol Noridem, is a pyrazolone analgesic presented as an injection solution for intramuscular and intravenous use. It treats acute pain, postoperative pain, fever, and colic in adult patients.

GNH USA supplies Metamizol Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizole is used for managing pain and fever through inhibition of prostaglandin synthesis and central pain modulation.

Acute pain: provides rapid analgesia for severe short‑term pain episodes. Post‑operative pain: reduces discomfort following surgical procedures. Fever: lowers elevated body temperature in febrile states. Colic: alleviates abdominal cramping associated with gastrointestinal colic.

Metamizole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the site of administration. - Transient hypotension: temporary drop in blood pressure after injection. - Nausea or vomiting: gastrointestinal upset occurring shortly after dosing. - Dizziness or flushing: mild circulatory sensations.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells, potentially life‑threatening. - Anaphylactic reaction: rapid onset of severe allergic symptoms. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: serious skin reactions. - Severe blood dyscrasias: including thrombocytopenia or hemolytic anemia. - Profound hypotension: marked blood pressure fall requiring medical intervention.

Metamizole should be used with caution in specific clinical situations.

Renal impairment: assess kidney function before use. Hepatic dysfunction: monitor liver enzymes during therapy. History of blood disorders: avoid in patients with prior agranulocytosis. Concomitant NSAIDs: increase risk of gastrointestinal bleeding. Pregnancy and breastfeeding: use only if clearly needed after risk assessment. Store at ambient temperature: keep in original container, protect from light and moisture.

Metamizole can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Bone‑marrow suppressants: may potentiate agranulocytosis. - Strong vasodilators: increase risk of severe hypotension. - Anticoagulants: elevate bleeding risk. - Sulfonamides: may heighten blood‑cell toxicity.

Moderate Interactions (Monitor Closely): - Other NSAIDs: additive gastrointestinal irritation. - Diuretics: enhanced hypotensive effect. - Certain antidepressants: potential for serotonin syndrome.